Pharmaceutical Preparations · DE · CIK 1590750
Viridian Therapeutics develops and commercializes medicines for serious and rare diseases, focusing on autoimmune disorders and thyroid eye disease
Comparable business profile · signals at a glance
In the 90 days to Dec 31, 2025: 1 insider bought $10.0M · 1 sold $71K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Tousignant JenniferChief Legal Officer | Sell | 2,272 | $31.16 | $71K |
| Oct 23, 2025 | Fairmount Healthcare Fund Ii Gp LlcDirector,TenPercentOwner | Buy | 454,545 | $22.00 | $10.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.